Pharma Talks

Nataliya Andreychuk
  • 0.0(0개의 평가)
  • 마케팅
  • 격주 업데이트

Join Nataliya Andreychuk, CEO of Viseven, on Pharma Talks – a podcast where human voices meet industry insights. Dive into engaging conversations with industry leaders, exploring the latest trends in pharma marketing, digital transformation, and AI-driven solutions. 🔗 Follow Nataliya on LinkedIn for more updates and insights: https://www.linkedin.com/in/andreychuk/ 🔗 Discover more about Viseven's digital solutions at viseven.com

  1. Content Supply Chain in Pharma | Pharma Talks

    2월 21일

    Content Supply Chain in Pharma | Pharma Talks

    Content Supply Chain in Pharma | Pharma Talks In this conversation, Nataliya Andreychuk and Prasant Vijayakumar discuss the importance of the content supply chain in the pharmaceutical industry, exploring how AI is transforming content development, the relevance of modular content, and the challenges faced in ensuring effective engagement. Takeaways Content supply chain is crucial for effective communication in pharma. AI is changing the landscape of content development. MLR processes can be streamlined to enhance efficiency. Modular content remains relevant in today's digital age. Structured data is essential for effective content management. Content velocity affects how quickly updates can be communicated. Localization is key to successful content adoption. Integration of various content formats is necessary for engagement. The future of content creation will involve more video formats. Challenging the status quo of MLR can lead to significant improvements. Chapters 00:00 Introduction to Content Supply Chain in Pharma 02:18 The Role of AI in Content Development 05:11 Modular Content: Relevance and Education 07:50 Challenges in Content Structure and Data 10:26 Content Velocity and Engagement 13:03 The Future of Content Supply Chain 15:58 Localization and Infrastructure in Content Delivery 18:50 Conclusion and Future Outlook Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/

    24분
  2. Rise of Digital Opinion Leaders in Pharma | Pharma Talks

    2월 11일

    Rise of Digital Opinion Leaders in Pharma | Pharma Talks

    In this episode of PharmaTalks, Nataliya Andreychuk explores the rise of digital opinion leaders with pharma omnichannel and digital engagement expert Pavlo Klymenko. The conversation goes beyond influencers and traditional key opinion leaders, focusing on a new type of voice emerging naturally in open and social media. Clinicians who build trust, share practical experience, and engage peers and patients in a more open, continuous way. Takeaways Digital opinion leaders are more than just influencers; they provide credible medical information.There is a significant gap between guidelines and real-world practices in healthcare.Patients increasingly seek information from social media rather than healthcare professionals.Effective communication requires constant dialogue with clinicians.Digital opinion leaders can help fill the gap left by misinformation online.Pharma must adapt to the fast-paced changes in healthcare communication.Engagement with digital opinion leaders should be honest and transparent.The role of digital opinion leaders is essential for product launch readiness.Pharma companies need to invest time and resources in building relationships with digital opinion leaders.Creating reusable content for digital opinion leaders can enhance communication efficiency. **** Chapters 00:00 Introduction to Digital Opinion Leaders 01:55 The Shift from KOLs to DOLs 03:33 Understanding Pharma's Engagement with DOLs 07:18 Challenges and Opportunities in Digital Engagement 11:09 The Role of Medical Governance in DOL Engagement 15:24 Building Effective Relationships with DOLs 17:28 Practical Steps for Pharma Companies 20:20 Hot or Not: Challenging the Status Quo *** 🔗 Links for more insights: https://viseven.com/key-opinion-leaders-in-pharma/https://viseven.com/healthcare-marketing-plan-guide/https://viseven.com/patient-engagement-in-pharma/https://viseven.com/pharma-crm/https://viseven.com/mlr-review-process-in-pharma-challenges-and-solutions/https://viseven.com/digital-transformation-in-pharma/https://viseven.com/life-sciences-industry-trends-2026/Follow Viseven, Nataliya, and Pavlo in social media: https://www.linkedin.com/company/2907491 https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/pavel-klymenko-2956395/

    24분
  3. Rethinking Omnichannel Marketing in Pharma | Pharma Talks

    2월 3일

    Rethinking Omnichannel Marketing in Pharma | Pharma Talks

    In this episode of PharmaTalks, Nataliya Andreychuk and Nico Renner discuss the evolving landscape of pharma marketing, particularly focusing on the concept of omnichannel marketing. They explore the challenges and misconceptions surrounding omnichannel strategies, the importance of personalization versus segmentation, and the role of AI in enhancing marketing efforts. The conversation emphasizes the need for a more human touch in marketing and practical steps that pharma teams can take to improve their strategies. Nico Renner is strictly sharing is personal views and opinion as an individual, not his current employer’s position on the discussed topics. Takeaways Omnichannel marketing is often misunderstood and overhyped. Personalization should be distinct from segmentation in marketing. The human element in marketing is crucial for effective engagement. AI can help streamline marketing processes but should focus on relevance. Pharma marketers face increasing pressure to be multifaceted experts. Segmentation can be more effective than personalization at scale. The industry needs to recalibrate its expectations from omnichannel strategies. Marketers should prioritize creating relevant content over sheer volume. The future of pharma marketing lies in understanding patient needs better. A more human touch in marketing will be increasingly valued. Chapters 00:00 Introduction to Omnichannel Marketing in Pharma 02:08 The Evolution of Pharma Marketing 04:46 Rethinking Omnichannel: Overrated or Misunderstood? 08:18 Personalization vs. Segmentation: A Misalignment? 19:22 Practical Steps for Pharma's Future 24:33 Hot or Not: Myths in Pharma Marketing 🔗 Links for more insights: https://viseven.com/omnichannel/ https://viseven.com/content-development/ https://viseven.com/difference-multichannel-omnichannel-pharma-communication-many-overlooked/ https://viseven.com/using-omnichannel-approach-to-achieve-better-hcp-engagement-how-does-it-work/ Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ Follow Viseven, Nataliya, and Paul in social media: https://www.linkedin.com/company/2907491/ https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/nicorenner

    26분
  4. Human Element in Digital Transformation | Pharma Talks

    1월 26일

    Human Element in Digital Transformation | Pharma Talks

    In this engaging conversation, Nataliya Andreychuk and Paul Tunnah discuss the evolving landscape of the pharmaceutical industry as they approach 2026. They explore the importance of digital transformation, emphasizing the need for a human-centric approach rather than a technology-first mindset. The discussion delves into the risks and rewards associated with AI in pharma, the significance of customer engagement, and the challenges of hyper-personalization versus effective segmentation. Takeaways Digital transformation must prioritize human change over technology. AI presents both risks and rewards that need careful consideration. Customer engagement strategies should focus on building trust and connection. Segmentation is crucial for effective communication in pharma. Hyper-personalization may not be the best approach for all situations. Content quality is essential to cut through the noise in marketing. Companies should embrace a mindset of continuous evolution and adaptation. Collaboration between IT and business leaders is vital for success. The future of pharma will require a balance between technology and human insight. 2026 will be a pivotal year for the pharmaceutical industry. Chapters 00:00 Introduction and Year-End Reflections 03:05 Digital Transformation and the Human Element 05:48 AI, Risk, and Reward in Pharma 08:35 Customer Engagement and the Future 11:28 Navigating AI and Content Creation 14:22 Hyper-Personalization vs. Segmentation 17:04 Hot or Not: Industry Predictions 25:52 Conclusion and Looking Ahead to 2026 Watch, listen, and reflect before you plan your 2026 strategy

    28분
  5. AI and Marketing: The Smart Shift in Pharma | Pharma Talks

    1월 16일

    AI and Marketing: The Smart Shift in Pharma | Pharma Talks

    Discover how AI is reshaping pharma – from marketing automation to intelligent sales strategies – with our guest Fredrik Holmboe. Listen to the new Pharma Talks episode with Nataliya Andreychuk! Together, they explore how the role of the modern marketeer is evolving – from content creators to AI-driven orchestrators of omnichannel engagement. The conversation uncovers how AI in sales and marketing is reshaping daily operations, driving smarter decisions, and creating a seamless bridge between sales, marketing, and medical teams. Key topics explored in this episode: The shift from traditional marketing to AI and digital marketing approaches.How AI for sales and marketing empowers teams with predictive insights and real-time personalization.Practical examples of AI-driven sales enablement and content intelligence tools improving HCP engagement.Bridging organizational silos through data intelligence, automation, and AI for customer experience.Fredrik's ABC+ Content Excellence Framework – helping life science companies enhance digital engagement in pharma and ensure unified messaging across all channels.What the future holds for AI adoption in life science, pharma business transformation, and human-AI co-creation. Tune in to discover where creativity meets intelligence, and technology becomes the enabler of more meaningful healthcare communication! Find out more about ABC+ Content Excellence Framework: https://www.dualia.se/ Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert Support Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ *** 0:00 Intro 03:14 The evolving role of marketers in Pharma 06:09 Real-world applications of AI in marketing 17:17 Bridging gaps: sales, marketing, and medical collaboration 22:59 The future of marketing: orchestrating AI tools *** Follow Viseven, Nataliya, and Fredrik in social media: https://www.linkedin.com/company/viseven/ https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/fredrikholmboe/ *** 🔗 Links for more insights: https://viseven.com/ai-data/ https://viseven.com/healthcare-data-analytics/ https://viseven.com/ai-medical-affairs/ https://viseven.com/list-of-ai-mistakes-pharma-companies-make/

    30분
  6. Pharma 2026: Connecting AI, People, and Processes | Pharma Talks with the Viseven Team

    2025. 12. 30.

    Pharma 2026: Connecting AI, People, and Processes | Pharma Talks with the Viseven Team

    In this episode, Viseven leaders reflect on the trends shaping the pharmaceutical industry today. The discussion focuses on how digital transformation is evolving from isolated initiatives into connected systems that support real business execution. Automation and AI are no longer optional, but their value depends on how well they are integrated into existing workflows and operating models. This episode looks ahead to what’s next for pharma and life sciences, and what it takes to operationalize AI in a way that strengthens teams rather than replaces them. Key topics explored in this episode: The pharmaceutical industry is increasingly focusing on digital transformation and automation.Companies are rationalizing their systems to integrate AI more effectively.AI should be part of the core processes, not a separate entity.People and processes are crucial for successful tech integration.2026 will see a shift from AI pilots to operationalized solutions.AI will be integrated into teams to enhance productivity.The role of professionals will evolve to be more technology-savvy and cross-functional.There are challenges in balancing AI capabilities with human creativity.The industry must adapt quickly to the changing landscape of AI.Strategic thinking in the AI era requires a new approach to roles and responsibilities.*** Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert Support Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ *** 00:00 Introduction to Pharma Talks and Team Insights 00:56 Trends in Pharma: Digital Transformation and Automation 03:04 The Role of People and Processes in Tech Integration 05:08 Forecasting 2026: Operationalizing AI in Pharma 08:27 Challenges and Opportunities in the AI Era *** Follow Viseven, Nataliya in social media: https://www.linkedin.com/company/viseven/ https://www.linkedin.com/in/andreychuk/

    31분
  7. Pharma Talks: Human Leadership + AI Adoption: Clear Strategy 2026

    2025. 12. 18.

    Pharma Talks: Human Leadership + AI Adoption: Clear Strategy 2026

    The discussion between Nataliya and Paul serves as a reminder that the pharmaceutical industry stands at a crossroads where embracing change can lead to unprecedented opportunities. By trusting their creativity, shifting their mindsets, and focusing on quality over quantity, professionals can navigate the evolving landscape and make a lasting impact in healthcare. Key topics explored in this episode: Technological change should be embraced, not feared. Understanding customer needs is crucial for innovation. Pharma must trust its own capabilities and creativity. Predictions for the future should be bold and visionary. Quality of content is more important than quantity. Compliance should be integrated into marketing strategies. Agility in launch strategies is essential for success. A human-centric approach is vital in the age of AI. Patient-centricity must be balanced with scientific integrity. Proactive engagement with technology will shape the future of pharma. Chapters 00:00 Introduction and Overview of Pharma's Future 02:31 Embracing Change in Pharma 05:16 The Role of Customer Insights 08:00 Trusting Ourselves in Pharma Marketing 10:50 Predictions for 2026: A Visionary Outlook 13:42 Content Production and Its Evolution 16:24 The Future of Compliance in Pharma 19:12 Rethinking Launch Strategies 23:13 Embracing Agility and Evolution in Marketing 25:00 The Human Element in AI Integration 27:40 Navigating the Future of Work and Technology 29:41 Rethinking Patient-Centricity in Healthcare 33:44 Rapid Fire Insights on Industry Trends Listen in for sharp insights, real-world experience, and a rapid-fire round that challenges some of omnichannel’s most common assumptions. Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert Support Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ *** Follow Viseven, Nataliya, and Paul in social media: https://www.linkedin.com/company/viseven/ https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/psimms/ ***

    39분
  8. How Pharma Must Rethink Omnichannel Engagement

    2025. 12. 12.

    How Pharma Must Rethink Omnichannel Engagement

    In this episode of Pharma Talks, Nataliya Andreychuk sits down with Yacin Marzouki for an honest conversation about why omnichannel in pharma still feels more complicated than it should be. The discussion goes beyond tools and tactics. Nataliya and Yacin explore blind spots inside pharma teams, the shift toward a true business-to-healthcare mindset, and what omnichannel maturity actually looks like in practice. Key topics explored in this episode: Omnichannel strategies in pharma need to evolve for success.Understanding HCPs' needs is crucial for effective engagement.Blind spots in data and insights hinder omnichannel effectiveness.Content strategy must be connected across all channels.Technology alone cannot solve omnichannel challenges.Local differences impact omnichannel strategies significantly.Emotional tech and empathy are the future of engagement.Chapters 00:00 Introduction to Omnichannel in Pharma 02:28 Guest Introduction and Background 05:20 Identifying Blind Spots in Pharma 11:57 Understanding HCP Needs and Engagement 16:12 Maturity Levels of Omnichannel Strategies 21:04 The Role of Content and Technology 28:45 Rapid Fire Round: Hot or Not Listen in for sharp insights, real-world experience, and a rapid-fire round that challenges some of omnichannel’s most common assumptions. Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ *** Follow Viseven, Nataliya, and Fredrik in social media: https://www.linkedin.com/company/viseven/ https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/fredrikholmboe/ *** 🔗 Links for more insights: https://viseven.com/ai-data/ https://viseven.com/healthcare-data-analytics/ https://viseven.com/ai-medical-affairs/ https://viseven.com/list-of-ai-mistakes-pharma-companies-make/

    30분
모두 보기(23개)

소개

Join Nataliya Andreychuk, CEO of Viseven, on Pharma Talks – a podcast where human voices meet industry insights. Dive into engaging conversations with industry leaders, exploring the latest trends in pharma marketing, digital transformation, and AI-driven solutions. 🔗 Follow Nataliya on LinkedIn for more updates and insights: https://www.linkedin.com/in/andreychuk/ 🔗 Discover more about Viseven's digital solutions at viseven.com

정보

  • 제작진
    Nataliya Andreychuk
  • 방송 연도
    2025년 - 2026년
  • 에피소드
    23
  • 등급
    전체 연령 사용가
  • 저작권
    © Viseven 2025
  • 웹사이트 보기
    Pharma Talks